Skip to content

Therapist-aided App for Exposure and Response Prevention in patients with Obsessive-Compulsive Disorder

Effectiveness, efficacy, and feasibility of a therapist-aided app for Exposure and Response Prevention: A Parallel-group, Pilot Randomised Control Trial - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072909
Enrollment
20
Registered
2024-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F422- Mixed obsessional thoughts and acts

Interventions

Intervention1: Exposure and Response Prevention (ERP): A trained therapist would provide weekly sessions for 4 weeks (total 4 sessions) of manual-based ERP sessions to patients diagnosed with Obsessiv

Sponsors

IHUB Anubhuti-IITD Foundation (IHUB)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18-40 years 2.Meeting diagnostic criteria for Obsessive Compulsive Disorder and per International Classification of Diseases-tenth edition (ICD-10) 3.Duration of illness= 2 years 4.Having access to smartphone 5.Able to read English and Hindi

Exclusion criteria

Exclusion criteria: 1. OCD with predominantly obsessions (without compulsions) 2.Depressive disorder with scores on Beck Depressive Inventory (BDI-II)= 14 3.Current active suicidal ideations 4.Patients with comorbid or history of severe mental illness such as schizophrenia, Bipolar affective disorder, Intellectual disability or Autism spectrum disorders 5.Patients with organic brain disorder or other neurological conditions 6.Unwilling or unable to provide consent

Design outcomes

Primary

MeasureTime frame
The primary outcome measure would be considered as the change in client adherence to homework of ERP therapy as assessed by Patient EX/RP Adherence Scale (PEAS).Timepoint: 1 week after the first session, week 2 (2nd session), week 3 (3rd session) and 4 weeks (4th session)

Secondary

MeasureTime frame
The secondary outcome would be measured by the change in OCD symptoms as measured by decrease in Y- BOCS scoreTimepoint: Baseline (Day 0) and Session 4 (Day 28);The secondary outcome would be measured by the change in OCD symptoms as measured by decrease in Clinicial Global Impression (CGI) scoreTimepoint: Baseline (Day 0) and Session 4 (Day 28)

Countries

India

Contacts

Public ContactSwati Kedia Gupta

All India Institute of Medical Sciences

swatikedia@aiims.edu9810140324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026